7 research outputs found
A reconstructed database of historic bluefin tuna captures in the Gibraltar Strait and Western Mediterranean
This data paper presents a reconstruction of a compilation of a small but consistent database of historical capture records of bluefin tuna (Thunnus thynnus; BFT hereafter) from the Gibraltar Strait and Western Mediterranean (Portugal, Spain and Italy). The compilation come from diverse historical and documentary sources and span the time interval from 1525 to 1936 covering a period of 412 years. There is a total of 3074 datum, which reach up to 67.83% of the total implying a 32.17% of missing data. However, we have only reconstructed the captures for the time interval 1700 1936 and we provide these reconstructions only for this time interval and for 9 out of 11 series due to the scarcity and inhomogeneity of the two oldest capture time series. This reconstructed database provides an invaluable opportunity for fisheries and marine research as well as for multidisciplinary research in climate change. © 2017 The AuthorsJ.M.P.M. was funded by a Basque Government post-doctoral fellowship. A. M. Caballero-Alfonso was funded by the Spanish Ministry of Education, Culture and Sports
Clonal chromosomal mosaicism and loss of chromosome Y in elderly men increase vulnerability for SARS-CoV-2
The pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2, COVID-19) had an estimated overall case fatality ratio of 1.38% (pre-vaccination), being 53% higher in males and increasing exponentially with age. Among 9578 individuals diagnosed with COVID-19 in the SCOURGE study, we found 133 cases (1.42%) with detectable clonal mosaicism for chromosome alterations (mCA) and 226 males (5.08%) with acquired loss of chromosome Y (LOY). Individuals with clonal mosaic events (mCA and/or LOY) showed a 54% increase in the risk of COVID-19 lethality. LOY is associated with transcriptomic biomarkers of immune dysfunction, pro-coagulation activity and cardiovascular risk. Interferon-induced genes involved in the initial immune response to SARS-CoV-2 are also down-regulated in LOY. Thus, mCA and LOY underlie at least part of the sex-biased severity and mortality of COVID-19 in aging patients. Given its potential therapeutic and prognostic relevance, evaluation of clonal mosaicism should be implemented as biomarker of COVID-19 severity in elderly people. Among 9578 individuals diagnosed with COVID-19 in the SCOURGE study, individuals with clonal mosaic events (clonal mosaicism for chromosome alterations and/or loss of chromosome Y) showed an increased risk of COVID-19 lethality
A reconstructed database of historic bluefin tuna captures in the Gibraltar Strait and Western Mediterranean
This data paper presents a reconstruction of a compilation of a small but consistent database of historical capture records of bluefin tuna (Thunnus thynnus; BFT hereafter) from the Gibraltar Strait and Western Mediterranean (Portugal, Spain and Italy). The compilation come from diverse historical and documentary sources and span the time interval from 1525 to 1936 covering a period of 412 years. There is a total of 3074 datum, which reach up to 67.83% of the total implying a 32.17% of missing data. However, we have only reconstructed the captures for the time interval 1700–1936 and we provide these reconstructions only for this time interval and for 9 out of 11 series due to the scarcity and inhomogeneity of the two oldest capture time series. This reconstructed database provides an invaluable opportunity for fisheries and marine research as well as for multidisciplinary research in climate change. Keywords: Data reconstructions, DINEOF, Missing data, Historic Bluefin tuna captures, Gibraltar Strait and Western Mediterranea
Climate effects on historic bluefin tuna captures in the Gibraltar Strait and Western Mediterranean
Contemporary use of cefazolin for MSSA infective endocarditis: analysis of a national prospective cohort
Objectives: This study aimed to assess the real use of cefazolin for methicillin-susceptible Staphylococcus aureus (MSSA) infective endocarditis (IE) in the Spanish National Endocarditis Database (GAMES) and to compare it with antistaphylococcal penicillin (ASP). Methods: Prospective cohort study with retrospective analysis of a cohort of MSSA IE treated with cloxacillin and/or cefazolin. Outcomes assessed were relapse; intra-hospital, overall, and endocarditis-related mortality; and adverse events. Risk of renal toxicity with each treatment was evaluated separately. Results: We included 631 IE episodes caused by MSSA treated with cloxacillin and/or cefazolin. Antibiotic treatment was cloxacillin, cefazolin, or both in 537 (85%), 57 (9%), and 37 (6%) episodes, respectively. Patients treated with cefazolin had significantly higher rates of comorbidities (median Charlson Index 7, P <0.01) and previous renal failure (57.9%, P <0.01). Patients treated with cloxacillin presented higher rates of septic shock (25%, P = 0.033) and new-onset or worsening renal failure (47.3%, P = 0.024) with significantly higher rates of in-hospital mortality (38.5%, P = 0.017). One-year IE-related mortality and rate of relapses were similar between treatment groups. None of the treatments were identified as risk or protective factors. Conclusion: Our results suggest that cefazolin is a valuable option for the treatment of MSSA IE, without differences in 1-year mortality or relapses compared with cloxacillin, and might be considered equally effective
Evolution over Time of Ventilatory Management and Outcome of Patients with Neurologic Disease∗
OBJECTIVES: To describe the changes in ventilator management over time in patients with neurologic disease at ICU admission and to estimate factors associated with 28-day hospital mortality. DESIGN: Secondary analysis of three prospective, observational, multicenter studies. SETTING: Cohort studies conducted in 2004, 2010, and 2016. PATIENTS: Adult patients who received mechanical ventilation for more than 12 hours. INTERVENTIONS: None. MEASUREMENTS AND MAIN RESULTS: Among the 20,929 patients enrolled, we included 4,152 (20%) mechanically ventilated patients due to different neurologic diseases. Hemorrhagic stroke and brain trauma were the most common pathologies associated with the need for mechanical ventilation. Although volume-cycled ventilation remained the preferred ventilation mode, there was a significant (p < 0.001) increment in the use of pressure support ventilation. The proportion of patients receiving a protective lung ventilation strategy was increased over time: 47% in 2004, 63% in 2010, and 65% in 2016 (p < 0.001), as well as the duration of protective ventilation strategies: 406 days per 1,000 mechanical ventilation days in 2004, 523 days per 1,000 mechanical ventilation days in 2010, and 585 days per 1,000 mechanical ventilation days in 2016 (p < 0.001). There were no differences in the length of stay in the ICU, mortality in the ICU, and mortality in hospital from 2004 to 2016. Independent risk factors for 28-day mortality were age greater than 75 years, Simplified Acute Physiology Score II greater than 50, the occurrence of organ dysfunction within first 48 hours after brain injury, and specific neurologic diseases such as hemorrhagic stroke, ischemic stroke, and brain trauma. CONCLUSIONS: More lung-protective ventilatory strategies have been implemented over years in neurologic patients with no effect on pulmonary complications or on survival. We found several prognostic factors on mortality such as advanced age, the severity of the disease, organ dysfunctions, and the etiology of neurologic disease